Orphinic Scientific is a life science development platform creating innovative solutions for orphan diseases and other indications with significant unmet medical needs.

Our strengths

Strong team with track records

Orphinic's core scientific team consist of experts with over 20 years experience in clinical development processes and their commercialization.

Affiliated CRO

The company’s competencies in clinical stage development are further enforced through a collaboration with a large clinical CRO operating in the CEE region.

Artificial Intelligence

The company uses an advanced search tool powered by AI to actively look for projects worldwide.

We shorten time to the market - our core value lies in affiliated CRO and an outstanding knowledge of the CEE market

Time is the silver bullet 

5x
faster
Patient recruitment to trials for generic diseases in CEE is shorter than in Western Europe and the US
20%
cut costs
Our affiliated CRO prioritises our clinical trials, which allows us to shorten clinical development by approx. 2 years

Central Eastern Europe represents the most attractive region for patient recruitment for two main reasons:

1
Speed of recruitiment
CEE countires have a unique healthcare system where patients with rare diseases are concentrated in a few academic centers across the countries
2
Data quality
With population of c. 300m people, CEE constitutes a large pool of data compliant with GCP standards

At Orphinic Scientifc, due to our decades
of experience we are familiar with CEE sites, 
processes, investigators involved in the clinical
trials in the region

We implement Artificial Intelligence to source projects long before they are visible to large marketplayers

Poland

Extensive contact network incl. grant organizations and accelerators

CEE

Wide contact network in the CEE incl. think tanks and accelerators

Accelerators
& Universities

Universities and accelerators around the world

AI

Early project pipeline development via AI based technology, which automatically spotlights projects meeting our selection criteria from renounced grant organizations worldwide
arrow-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram